Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C499703-50 50 µg $294 
LS-C499703-100 100 µg $360 
Antibody

Polyclonal Rabbit anti‑Human RPS6KA4 / MSK2 / RSK‑B Antibody (FITC) LS‑C499703

Polyclonal Rabbit anti‑Human RPS6KA4 / MSK2 / RSK‑B Antibody (FITC) LS‑C499703

Antibody:
RPS6KA4 / MSK2 / RSK-B Rabbit anti-Human Polyclonal (FITC) Antibody
Application:
ELISA
Reactivity:
Human
Format:
FITC, Unmodified
Other formats:
Price
Catalog Number
$294
LS-C499703-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
RPS6KA4 / MSK2 / RSK-B Rabbit anti-Human Polyclonal (FITC) Antibody
Application:
ELISA
Reactivity:
Human
Format:
FITC, Unmodified
Other formats:

Specifications

Description
RSK-B antibody LS-C499703 is an FITC-conjugated rabbit polyclonal antibody to human RSK-B (RPS6KA4 / MSK2). Validated for ELISA.
Target
Human RPS6KA4 / MSK2 / RSK-B
Synonyms
RPS6KA4 | MSK2 | RSKB | Ribosomal protein kinase B | RSK-B | S6K-alpha-4
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
FITC. Also available Unconjugated or conjugated with Biotin, HRP.
Purification
Protein G purified
Modifications
Unmodified
Immunogen
Recombinant Human Ribosomal protein S6 kinase alpha-4 protein (237-393AA)
Specificity
Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors.
Applications
  • ELISA
  • Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.03% Proclin 300, 50% glycerol.
Storage
Short term: -20°C; Long term: -80°C; Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About RPS6KA4 / MSK2 / RSK-B
O75676 NM_003942 NP_003933.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/28/2024